OsteoCentric Technologies Acquires Integrity SI-Fusion from Lincotek

OsteoCentric Technologies, a pioneer of bone fixation in the orthopedic and dental space, is excited to announce the acquisition of the Integrity-SI Fusion System from Lincotek Medical. The system’s implants and instruments, designed in collaboration with Mayo Clinic, incorporates the principles of fusion. OsteoCentric will apply UnifiMI (Mechanical Integration)—their proprietary, less-invasive method of securing implants to bone—to optimize the stability of the Integrity-SI implant.
 
The addition of this FDA-cleared system to its portfolio will bring new opportunities to the company. “By combining the system with UnifiMI, we expect it to provide significant expansion to both the orthopedic trauma and spine markets. Strategically, this will be the first of several new UnifiMI product offerings to address the needs of surgeons,” said Andrew Fauth, chief technology officer for OsteoCentric Technologies. 
 
The implants and instruments of the Integrity-SI Fusion system are highly optimized for the sacroiliac (SI) joint and designed for maximal compression and stability. The percutaneous system facilitates the application of bone graft following the robust decortication of the fusion site.
 
Dr. William “Woodie” Cross, one of the key developing surgeons and an Orthopedic Surgeon with Mayo Clinic, commented on the system, “With Integrity-SI, we have established a reawakening of fusion principles as it pertains to the SI joint. The coupling of UnifiMI significantly enhances the already established Integrity-SI approach, and will improve patient outcomes, which has always been the focus of my practice.”
 
Mayo Clinic and Dr. William Cross have a financial interest in the technology referenced in this news release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.